Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas
A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not liable after a boy consumed the companies’ cow’s milk-based products for premature infants and became severely ill.
CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...
Shares of Abbott Laboratories ABT rose 4.61% to $118.60 Friday, on what proved to be an all-around positive trading session ...
Oppenheimer analyst Suraj Kalia maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...
At least two people were killed and six others injured with gunshot wounds after a teenage shooter opened fire in two locations in downtown Orlando where large crowds had gathered to celebrate ...
Shares of Abbott Laboratories and Reckitt Benckiser rose Friday after the companies won a victory in litigation over the safety of some of their baby-formula products. Abbott shares rose 4% in early ...
A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on United Therapeutics (UTHR – Research ...
A judge barred Kirkland & Ellis partner James Hurst from making arguments for Abbott Laboratories in a major trial over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback